Oncology & Cancer

Gut bacteria linked to ovarian cancer treatment resistance

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment. Doctors may be able to use the findings ...

Oncology & Cancer

Unlocking new insights into hereditary ovarian cancer risk

Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most prevalent and deadliest forms of ovarian cancer. Their work is published in the journal npj Genomic ...

Oncology & Cancer

How chemotherapy primes ovarian cancer for immune-based therapies

Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These findings could lead to personalized therapies that target the right patients at the right time, ...

Oncology & Cancer

New clinical pathway supports cancer recurrence anxiety

Researchers have developed a three-step plan to support those burdened by the intense fear of cancer recurrence. This plan offers a consistent, streamlined approach to managing recurrence anxiety, empowering patients to regain ...

page 6 from 40